Evidence map›Paper›PMID 35145520›Full record

ArticleFrontiers in immunology2022

Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.

Ching-Fen Shen, Chia-Liang Yen, Yi-Chen Fu, Chao-Min Cheng, Tzu-Chi Shen, Pei-De Chang, Kuang-Hsiung Cheng, Ching-Chuan Liu, Yu-Tzu Chang, Po-Lin Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. COVID-19 vaccines: current and future challenges.Frontiers in pharmacology · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ching-Fen ShenInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Chia-Liang YenInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Yi-Chen FuInstitute of Biomedical Engineering, National Tsing Hua University, Hsinchu City, Taiwan.
Chao-Min ChengInstitute of Biomedical Engineering, National Tsing Hua University, Hsinchu City, Taiwan.
Tzu-Chi ShenInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Pei-De ChangInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Kuang-Hsiung ChengDepartment of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Ching-Chuan LiuDepartment of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Yu-Tzu ChangDepartment of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Po-Lin ChenDepartment of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Wen-Chien KoDepartment of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Chi-Chang ShiehInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
National Cheng Kung University Hospital · TWNational Cheng Kung University · TWNational Tsing Hua University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Innate immunity, armed with pattern recognition receptors including Toll-like receptors (TLR), is critical for immune cell activation and the connection to anti-microbial adaptive immunity. However, information regarding the impact of age on the innate immunity in response to SARS-CoV2 adenovirus vector vaccines and its association with specific immune responses remains scarce. Methods: Fifteen subjects between 25-35 years (the young group) and five subjects between 60-70 years (the older adult group) were enrolled before ChAdOx1 nCoV-19 (AZD1222) vaccination. We determined activation markers and cytokine production of monocyte, natural killer (NK) cells and B cells Results: The older adult vaccinees had weaker vaccine-induced sVNTs than young vaccinees after 1 Conclusions: The innate immune responses after the first vaccination correlated with the neutralizing antibody production. Older people may have defective innate immune responses by TLR stimulation and weak or delayed innate immune activation profile after vaccination compared with young people.

Indexed as

AdultAgedAntibodies, NeutralizingAntibodies, ViralB-LymphocytesChAdOx1 nCoV-19COVID-19FemaleHumansImiquimodImmunity, InnateImmunosenescenceInterferon-gammaKiller Cells, NaturalMaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralChAdOx1 nCoV-19IFNG protein, humanImiquimodInterferon-gammaPoly I-CToll-Like Receptorsadenoviral vector vaccineimmunosenescenceinnate immuneneutralizing antibodiesSARS-CoV-2 vaccines

Identifiers

PMID35145520
PMCPMC8822242
OpenAlexW4206899236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.